Login Register Cart 0
Generic placeholder image

Infectious Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5265
ISSN (Online): 2212-3989

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Systematic Review Article

Breast Cancer Risk and Human Papillomavirus Infection: A Bradford Hill Criteria Based Evaluation

Author(s): Muhammad Usman, Yasir Hameed*, Mukhtiar Ahmad, Jalil Ur Rehman, Hamad Ahmed, Muhammad Safdar Hussain, Rizwan Asif, Muhammad Ghulam Murtaza, Muhammad Tayyab Jawad and Muhammad Junaid Iqbal

Volume 22, Issue 4, 2022

Published on: 01 March, 2022

Article ID: e200122200389 Pages: 10

DOI: 10.2174/1573401318666220120105931

Price: $65

Abstract

Background: The association between human papillomavirus (HPV) and human breast cancer (BC) has already been thoroughly studied worldwide with contradictory findings. Although the researchers have tried to minimize the conflict using statistical meta-analysis because of its shortcomings, there is still a need to evaluate the correlation between HPV and BC using any additional method.

Objectives: This study was launched to investigate the correlation between HPV and BC through the application of Bradford Hill criteria postulates.

Methods: Population-wide studies associating HPV with BC were searched using the PubMed database. Then, the information of HPV burden in BC, normal/benign samples was analyzed, and ultimately Bradford Hill criteria postulates were applied on the collected evidence to explore the relationship between HPV and BC. In addition, to make the outcomes more authentic, we also reviewed the methodologies of previous studies to address the propensity of false results.

Results: After a careful evaluation of the obtained data against major Bradford Hill criteria postulates, it was noted that all these postulates, including strength, consistency, biological gradient, temporality, plausibility, experiment, specificity, and analogy were not fulfilled.

Conclusion: The results of the present study have failed to establish a causal association between HPV and BC, but they did suggest HPV as a cause-effective agent or at least a co-participant in the pathogenesis of BC. Because of the weakness of association, particularly the lack of consistency between studies and the lack of effect specificity, more research into Bradford Hill criteria postulates is required.

Keywords: Breast cancer (BC), bradford hill criteria, human papillomavirus (HPV), temporality, analogy, biological gradient.

Graphical Abstract

[1]
Weiss JR, Moysich KB, Swede H. Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14(1): 20-6.
[PMID: 15668471]
[2]
Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK. Various types and management of breast cancer: An overview. J Adv Pharm Technol Res 2010; 1(2): 109-26.
[PMID: 22247839]
[3]
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69(1): 7-34.
[http://dx.doi.org/10.3322/caac.21551] [PMID: 30620402]
[4]
Stone SC, Rossetti RA, Lima AM, Lepique AP. HPV associated tumor cells control tumor microenvironment and leukocytosis in experimental models. Immun Inflamm Dis 2014; 2(2): 63-75.
[http://dx.doi.org/10.1002/iid3.21] [PMID: 25400927]
[5]
Goldszmid RS, Dzutsev A, Trinchieri G. Host immune response to infection and cancer: unexpected commonalities. Cell Host Microbe 2014; 15(3): 295-305.
[http://dx.doi.org/10.1016/j.chom.2014.02.003] [PMID: 24629336]
[6]
Nicolini A, Carpi A, Rossi G. Cytokines in breast cancer. Cytokine Growth Factor Rev 2006; 17(5): 325-37.
[http://dx.doi.org/10.1016/j.cytogfr.2006.07.002] [PMID: 16931107]
[7]
Knüpfer H, Preiss R. Significance of interleukin-6 (IL-6) in breast cancer. (review) Breast Cancer Res Treat 2007; 102(2): 129-35.
[http://dx.doi.org/10.1007/s10549-006-9328-3] [PMID: 16927176]
[8]
Lewis AM, Varghese S, Xu H, Alexander HR. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med 2006; 4: 48-8.
[http://dx.doi.org/10.1186/1479-5876-4-48] [PMID: 17096856]
[9]
Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J. The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res 2015; 35(1): 1-16.
[http://dx.doi.org/10.1089/jir.2014.0026] [PMID: 25068787]
[10]
Karin M, Greten FR. NF-kappaB: Linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 2005; 5(10): 749-59.
[http://dx.doi.org/10.1038/nri1703] [PMID: 16175180]
[11]
Pacifico F, Leonardi A. Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol 2010; 321(1): 29-35.
[http://dx.doi.org/10.1016/j.mce.2009.10.010] [PMID: 19879919]
[12]
Haklar G, Sayin-Ozveri E, Yüksel M, Aktan AO, Yalçin AS. Different kinds of reactive oxygen and nitrogen species were detected in colon and breast tumors. Cancer Lett 2001; 165(2): 219-24.
[http://dx.doi.org/10.1016/S0304-3835(01)00421-9] [PMID: 11275372]
[13]
Li W, Tian S, Wang P, et al. The characteristics of HPV integration in cervical intraepithelial cells. J Cancer 2019; 10(12): 2783-7.
[http://dx.doi.org/10.7150/jca.31450] [PMID: 31258786]
[14]
Daudt C, da Silva FRC, Streck AF, et al. How many papillomavirus species can go undetected in papilloma lesions? Sci Rep 2016; 6: 36480.
[http://dx.doi.org/10.1038/srep36480] [PMID: 27808255]
[15]
Kan CY, Iacopetta BJ, Lawson JS, Whitaker NJ. Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer 2005; 93(8): 946-8.
[http://dx.doi.org/10.1038/sj.bjc.6602778] [PMID: 16222323]
[16]
Morshed K, Polz-Gruszka D, Szymański M, Polz-Dacewicz M. Human Papillomavirus (HPV) - structure, epidemiology and pathogenesis. Otolaryngol Pol 2014; 68(5): 213-9.
[http://dx.doi.org/10.1016/j.otpol.2014.06.001] [PMID: 25283316]
[17]
Hausen ZH. Papillomaviruses and cancer: From basic studies to clinical application. Nat Rev Cancer 2002; 2(5): 342-50.
[http://dx.doi.org/10.1038/nrc798] [PMID: 12044010]
[18]
Jackson S, Harwood C, Thomas M, Banks L, Storey A. Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes Dev 2000; 14(23): 3065-73.
[http://dx.doi.org/10.1101/gad.182100] [PMID: 11114894]
[19]
Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat 2005; 37(6): 319-24.
[http://dx.doi.org/10.4143/crt.2005.37.6.319] [PMID: 19956366]
[20]
Fackenthal JD, Olopade OI. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 2007; 7(12): 937-48.
[http://dx.doi.org/10.1038/nrc2054] [PMID: 18034184]
[21]
Zhang Y, Fan S, Meng Q, et al. BRCA1 interaction with human papillomavirus oncoproteins. J Biol Chem 2005; 280(39): 33165-77.
[http://dx.doi.org/10.1074/jbc.M505124200] [PMID: 15983032]
[22]
Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74-108.
[http://dx.doi.org/10.3322/canjclin.55.2.74] [PMID: 15761078]
[23]
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370(9590): 890-907.
[http://dx.doi.org/10.1016/S0140-6736(07)61416-0] [PMID: 17826171]
[24]
Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer. Breast Cancer Res Treat 1992; 21(2): 95-100.
[http://dx.doi.org/10.1007/BF01836955] [PMID: 1320958]
[25]
Ahangar-Oskouee M, Shahmahmoodi S, Jalilvand S, et al. No detection of ‘high-risk’ human papillomaviruses in a group of Iranian women with breast cancer. Asian Pac J Cancer Prev 2014; 15(9): 4061-5.
[http://dx.doi.org/10.7314/APJCP.2014.15.9.4061] [PMID: 24935597]
[26]
Ali SHM, Al-Alwan NAS, Al-Alwany SHM. Detection and genotyping of human papillomavirus in breast cancer tissues from Iraqi patients. East Mediterr Health J 2014; 20(6): 372-7.
[http://dx.doi.org/10.26719/2014.20.6.372]
[27]
Bakhtiyrizadeh S, Hosseini SY, Yaghobi R, Safaei A, Sarvari J. Almost complete lack of human cytomegalovirus and human papillomaviruses genome in benign and malignant breast lesions in Shiraz, Southwest of Iran. Asian Pac J Cancer Prev 2017; 18(12): 3319-24.
[PMID: 29286226]
[28]
Balci FL, Uras C, Feldman SM. Is human papillomavirus associated with breast cancer or papilloma presenting with pathologic nipple discharge? Cancer Treat Res Commun 2019; 19: 100122.
[http://dx.doi.org/10.1016/j.ctarc.2019.100122] [PMID: 30785026]
[29]
de León DC, Montiel DP, Nemcova J, et al. Human papillomavirus (HPV) in breast tumors: prevalence in a group of Mexican patients. BMC Cancer 2009; 9(1): 26.
[http://dx.doi.org/10.1186/1471-2407-9-26] [PMID: 19161629]
[30]
Chang P, Wang T, Yao Q, et al. Absence of human papillomavirus in patients with breast cancer in north-west China. Med Oncol 2012; 29(2): 521-5.
[http://dx.doi.org/10.1007/s12032-011-9945-5] [PMID: 21499926]
[31]
Choi Y-L, Cho EY, Kim JH, et al. Detection of human papillomavirus DNA by DNA chip in breast carcinomas of Korean women. Tumour Biol 2007; 28(6): 327-32.
[http://dx.doi.org/10.1159/000124238] [PMID: 18391549]
[32]
Damin APS, Karam R, Zettler CG, Caleffi M, Alexandre CO. Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat 2004; 84(2): 131-7.
[http://dx.doi.org/10.1023/B:BREA.0000018411.89667.0d] [PMID: 14999143]
[33]
de Villiers E-M, Sandstrom RE, zur Hausen H, Buck CE. Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res 2005; 7(1): R1-R11.
[http://dx.doi.org/10.1186/bcr940] [PMID: 15642157]
[34]
Delgado-García S, Martínez-Escoriza JC, Alba A, et al. Presence of human papillomavirus DNA in breast cancer: A Spanish case-control study. BMC Cancer 2017; 17(1): 320.
[http://dx.doi.org/10.1186/s12885-017-3308-3] [PMID: 28482874]
[35]
Doosti M, Bakhshesh M, Zahir ST, Shayestehpour M, Karimi-Zarchi M. Lack of evidence for a relationship between high risk human papillomaviruses and breast cancer in Iranian patients. Asian Pac J Cancer Prev 2016; 17(9): 4357-61.
[PMID: 27797244]
[36]
ElAmrani A, Gheit T, Benhessou M, et al. Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer. Papillomavirus Res 2018; 5: 150-5.
[http://dx.doi.org/10.1016/j.pvr.2018.04.003] [PMID: 29660489]
[37]
Fernandes A, Pesci-Feltri A, García-Fleury I, et al. Lymphocyte subsets predictive value and possible involvement of human papilloma virus infection on breast cancer molecular subtypes. World J Clin Oncol 2018; 9(7): 123-32.
[http://dx.doi.org/10.5306/wjco.v9.i7.123] [PMID: 30425937]
[38]
Frega A, Lorenzon L, Bononi M, et al. Evaluation of E6 and E7 mRNA expression in HPV DNA positive breast cancer. Eur J Gynaecol Oncol 2012; 33(2): 164-7.
[PMID: 22611956]
[39]
Fu L, Wang D, Shah W, Wang Y, Zhang G, He J. Association of human papillomavirus type 58 with breast cancer in Shaanxi province of China. J Med Virol 2015; 87(6): 1034-40.
[http://dx.doi.org/10.1002/jmv.24142] [PMID: 25676062]
[40]
Gannon OM, Antonsson A, Milevskiy M, Brown MA, Saunders NA, Bennett IC. No association between HPV positive breast cancer and expression of human papilloma viral transcripts. Sci Rep 2015; 5: 18081.
[http://dx.doi.org/10.1038/srep18081] [PMID: 26658849]
[41]
Glenn WK, Heng B, Delprado W, Iacopetta B, Whitaker NJ, Lawson JS. Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer. PLoS One 2012; 7(11): e48788.
[http://dx.doi.org/10.1371/journal.pone.0048788] [PMID: 23183846]
[42]
Glenn WK, Whitaker NJ, Lawson JS. High risk human papillomavirus and Epstein Barr virus in human breast milk. BMC Res Notes 2012; 5: 477-7.
[http://dx.doi.org/10.1186/1756-0500-5-477] [PMID: 22937830]
[43]
Gumus M, Yumuk PF, Salepci T, et al. HPV DNA frequency and subset analysis in human breast cancer patients’ normal and tumoral tissue samples. J Exp Clin Cancer Res 2006; 25(4): 515-21.
[PMID: 17310842]
[44]
Islam S, Dasgupta H, Roychowdhury A, et al. Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication. PLoS One 2017; 12(2): e0172760.
[http://dx.doi.org/10.1371/journal.pone.0172760] [PMID: 28245287]
[45]
Khodabandehlou N, Mostafaei S, Etemadi A, et al. Human papilloma virus and breast cancer: the role of inflammation and viral expressed proteins. BMC Cancer 2019; 19(1): 61.
[http://dx.doi.org/10.1186/s12885-019-5286-0] [PMID: 30642295]
[46]
Kouloura A, Nicolaidou E, Misitzis I, et al. HPV infection and breast cancer. Results of a microarray approach. Breast 2018; 40: 165-9.
[http://dx.doi.org/10.1016/j.breast.2018.05.010] [PMID: 29890463]
[47]
Lawson JS, Glenn WK. Multiple oncogenic viruses are present in human breast tissues before development of virus associated breast cancer. Infect Agent Cancer 2017; 12: 55.
[http://dx.doi.org/10.1186/s13027-017-0165-2] [PMID: 29075317]
[48]
Lawson JS, Glenn WK, Salyakina D, et al. Human papilloma virus identification in breast cancer patients with previous cervical neoplasia. Front Oncol 2016; 5: 298.
[http://dx.doi.org/10.3389/fonc.2015.00298] [PMID: 26779441]
[49]
Li J, Ding J, Zhai K. Detection of human papillomavirus DNA in patients with breast tumor in China. PLoS One 2015; 10(8): e0136050.
[http://dx.doi.org/10.1371/journal.pone.0136050] [PMID: 26295705]
[50]
Liang W, Wang J, Wang C, et al. Detection of high-risk human papillomaviruses in fresh breast cancer samples using the hybrid capture 2 assay. J Med Virol 2013; 85(12): 2087-92.
[http://dx.doi.org/10.1002/jmv.23703] [PMID: 23959946]
[51]
Malekpour Afshar R, Balar N, Mollaei HR, Arabzadeh SA, Iranpour M. Low prevalence of human papilloma virus in patients with breast cancer, Kerman; Iran. Asian Pac J Cancer Prev 2018; 19(11): 3039-44.
[http://dx.doi.org/10.31557/APJCP.2018.19.11.3039] [PMID: 30485938]
[52]
Mendizabal-Ruiz AP, Morales JA, Ramírez-Jirano LJ, Padilla-Rosas M, Morán-Moguel MC, Montoya-Fuentes H. Low frequency of human papillomavirus DNA in breast cancer tissue. Breast Cancer Res Treat 2009; 114(1): 189-94.
[http://dx.doi.org/10.1007/s10549-008-9989-1] [PMID: 18373273]
[53]
Mou X, Chen L, Liu F, et al. Low prevalence of human papillomavirus (HPV) in Chinese patients with breast cancer. J Int Med Res 2011; 39(5): 1636-44.
[http://dx.doi.org/10.1177/147323001103900506] [PMID: 22117964]
[54]
Naushad W, Surriya O, Sadia H. Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer. Infect Genet Evol 2017; 54: 230-7.
[http://dx.doi.org/10.1016/j.meegid.2017.07.010] [PMID: 28705719]
[55]
Ngan C, Lawson JS, Clay R, Delprado W, Whitaker NJ, Glenn WK. Early Human Papilloma Virus (HPV) oncogenic influences in breast cancer. Breast Cancer (Auckl) 2015; 9: 93-7.
[http://dx.doi.org/10.4137/BCBCR.S35692] [PMID: 26691275]
[56]
Salman NA, Davies G, Majidy F, et al. Association of high risk human papillomavirus and breast cancer: A UK based Study. Sci Rep 2017; 7: 43591.
[http://dx.doi.org/10.1038/srep43591] [PMID: 28240743]
[57]
Sigaroodi A, Nadji SA, Naghshvar F, Nategh R, Emami H, Velayati AA. Human papillomavirus is associated with breast cancer in the north part of Iran. Sci World J 2012; 2012: 837191-1.
[http://dx.doi.org/10.1100/2012/837191] [PMID: 22566779]
[58]
Vernet-Tomas M, Mena M, Alemany L, et al. Human papillomavirus and breast cancer: no evidence of association in a Spanish set of cases. Anticancer Res 2015; 35(2): 851-6.
[PMID: 25667466]
[59]
Wang D, Fu L, Shah W, et al. Presence of high risk HPV DNA but indolent transcription of E6/E7 oncogenes in invasive ductal carcinoma of breast. Pathol Res Pract 2016; 212(12): 1151-6.
[http://dx.doi.org/10.1016/j.prp.2016.09.009] [PMID: 27688086]
[60]
Bae J-M, Kim EH. Human papillomavirus infection and risk of breast cancer: A meta-analysis of case-control studies. Infect Agent Cancer 2016; 11: 14-4.
[http://dx.doi.org/10.1186/s13027-016-0058-9] [PMID: 26981149]
[61]
Höfler M. The Bradford Hill considerations on causality: A counterfactual perspective. Emerg Themes Epidemiol 2005; 2: 11-1.
[http://dx.doi.org/10.1186/1742-7622-2-11] [PMID: 16269083]
[62]
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15): 2008-12.
[http://dx.doi.org/10.1001/jama.283.15.2008] [PMID: 10789670]
[63]
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25(9): 603-5.
[http://dx.doi.org/10.1007/s10654-010-9491-z] [PMID: 20652370]
[64]
Akil N, Yasmeen A, Kassab A, Ghabreau L, Darnel AD, Al Moustafa AE. High-risk human papillomavirus infections in breast cancer in Syrian women and their association with Id-1 expression: A tissue microarray study. Br J Cancer 2008; 99(3): 404-7.
[http://dx.doi.org/10.1038/sj.bjc.6604503] [PMID: 18648363]
[65]
Al Moustafa AE, Al-Antary N, Aboulkassim T, Akil N, Batist G, Yasmeen A. Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer. Hum Vaccin Immunother 2016; 12(7): 1936-9.
[http://dx.doi.org/10.1080/21645515.2016.1139255] [PMID: 27082145]
[66]
Antonsson A, Spurr TP, Chen AC, et al. High prevalence of human papillomaviruses in fresh frozen breast cancer samples. J Med Virol 2011; 83(12): 2157-63.
[http://dx.doi.org/10.1002/jmv.22223] [PMID: 22012724]
[67]
Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD. Limited evidence of human papillomavirus in [corrected] breast tissue using molecular in situ methods. Cancer 2012; 118(5): 1212-20.
[http://dx.doi.org/10.1002/cncr.26389] [PMID: 21823105]
[68]
Bratthauer GL, Tavassoli FA, O’Leary TJ. Etiology of breast carcinoma: No apparent role for papillomavirus types 6/11/16/18. Pathol Res Pract 1992; 188(3): 384-6.
[http://dx.doi.org/10.1016/S0344-0338(11)81229-X] [PMID: 1320761]
[69]
Corbex M, Bouzbid S, Traverse-Glehen A, et al. Prevalence of papillomaviruses, polyomaviruses, and herpesviruses in triple-negative and inflammatory breast tumors from algeria compared with other types of breast cancer tumors. PLoS One 2014; 9(12): e114559.
[http://dx.doi.org/10.1371/journal.pone.0114559] [PMID: 25478862]
[70]
de Cremoux P, Thioux M, Lebigot I, Sigal-Zafrani B, Salmon R, Sastre-Garau X. Institut Curie Breast Group. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat 2008; 109(1): 55-8.
[http://dx.doi.org/10.1007/s10549-007-9626-4] [PMID: 17624590]
[71]
Ghaffari H, Nafissi N, Hashemi-Bahremani M, et al. Molecular prevalence of human papillomavirus infection among Iranian women with breast cancer. Breast Dis 2018; 37(4): 207-13.
[http://dx.doi.org/10.3233/BD-180333] [PMID: 30124441]
[72]
Ghaffari SR, Sabokbar T, Meshkat Z, et al. Tracing human papilloma virus in breast tumors of Iranian breast cancer patients. Breast J 2011; 17(2): 218-9.
[http://dx.doi.org/10.1111/j.1524-4741.2010.01053.x] [PMID: 21276129]
[73]
Gopalkrishna V, Singh UR, Sodhani P, et al. Absence of human papillomavirus DNA in breast cancer as revealed by polymerase chain reaction. Breast Cancer Res Treat 1996; 39(2): 197-202.
[http://dx.doi.org/10.1007/BF01806186] [PMID: 8872328]
[74]
Habyarimana T, Attaleb M, Mazarati JB, Bakri Y, El Mzibri M. Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients. Breast Cancer 2018; 25(2): 127-33.
[http://dx.doi.org/10.1007/s12282-018-0831-2] [PMID: 29350329]
[75]
Hachana M, Ziadi S, Amara K, Toumi I, Korbi S, Trimeche M. No evidence of human papillomavirus DNA in breast carcinoma in Tunisian patients. Breast 2010; 19(6): 541-4.
[http://dx.doi.org/10.1016/j.breast.2010.05.007] [PMID: 20547456]
[76]
Hedau S, Kumar U, Hussain S, et al. Breast cancer and human papillomavirus infection: No evidence of HPV etiology of breast cancer in Indian women. BMC Cancer 2011; 11: 27-7.
[http://dx.doi.org/10.1186/1471-2407-11-27] [PMID: 21247504]
[77]
Hennig EM, Suo Z, Thoresen S, Holm R, Kvinnsland S, Nesland JM. Human papillomavirus 16 in breast cancer of women treated for high grade Cervical Intraepithelial Neoplasia (CIN III). Breast Cancer Res Treat 1999; 53(2): 121-35.
[http://dx.doi.org/10.1023/A:1006162609420] [PMID: 10326789]
[78]
Herrera-Goepfert R, Vela-Chávez T, Carrillo-García A, et al. High-risk Human Papillomavirus (HPV) DNA sequences in metaplastic breast carcinomas of Mexican women. BMC Cancer 2013; 13: 445-5.
[http://dx.doi.org/10.1186/1471-2407-13-445] [PMID: 24083491]
[79]
Herrera-Romano L, Fernández-Tamayo N, Gómez-Conde E, et al. Absence of human papillomavirus sequences in epithelial breast cancer in a Mexican female population. Med Oncol 2012; 29(3): 1515-7.
[http://dx.doi.org/10.1007/s12032-011-0059-x] [PMID: 21909942]
[80]
Hossein R, Behzad S, Tahar M, Azadeh NA. Prevalence of human papillomavirus genotypes associated with cervical and breast cancers in Iran. Monoclon Antib Immunodiagn Immunother 2013; 32(6): 399-403.
[http://dx.doi.org/10.1089/mab.2013.0047] [PMID: 24328743]
[81]
Ilahi NE, Anwar S, Noreen M, Hashmi SN, Murad S. Detection of human papillomavirus-16 DNA in archived clinical samples of breast and lung cancer patients from North Pakistan. J Cancer Res Clin Oncol 2016; 142(12): 2497-502.
[http://dx.doi.org/10.1007/s00432-016-2251-z] [PMID: 27613186]
[82]
Khammapirad T, Prueksadee J, Diaz-Arrastia C, et al. Intraductal papilloma of the breast in association with preoncogenic gene of breast cancer. Asian Pac J Trop Biomed 2011; 1(2): 161-3.
[http://dx.doi.org/10.1016/S2221-1691(11)60017-8] [PMID: 23569749]
[83]
Khan NA, Castillo A, Koriyama C, et al. Human papillomavirus detected in female breast carcinomas in Japan. Br J Cancer 2008; 99(3): 408-14.
[http://dx.doi.org/10.1038/sj.bjc.6604502] [PMID: 18648364]
[84]
Kroupis C, Markou A, Vourlidis N, Dionyssiou-Asteriou A, Lianidou ES. Presence of high-risk human papillomavirus sequences in breast cancer tissues and association with histopathological characteristics. Clin Biochem 2006; 39(7): 727-31.
[http://dx.doi.org/10.1016/j.clinbiochem.2006.03.005] [PMID: 16780823]
[85]
Li T, Lu ZM, Guo M, et al. p53 codon 72 polymorphism (C/G) and the risk of human papillomavirus-associated carcinomas in China. Cancer 2002; 95(12): 2571-6.
[http://dx.doi.org/10.1002/cncr.11008] [PMID: 12467072]
[86]
Lindel K, Forster A, Altermatt HJ, Greiner R, Gruber G. Breast cancer and human papillomavirus (HPV) infection: No evidence of a viral etiology in a group of Swiss women. Breast 2007; 16(2): 172-7.
[http://dx.doi.org/10.1016/j.breast.2006.09.001] [PMID: 17088061]
[87]
Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers. J Hum Virol 2001; 4(6): 329-34.
[PMID: 12082399]
[88]
Mohtasebi P, Rassi H, Maleki F, et al. Detection of human papillomavirus genotypes and major BRCA mutations in familial breast cancer. Monoclon Antib Immunodiagn Immunother 2016; 35(3): 135-40.
[http://dx.doi.org/10.1089/mab.2015.0081] [PMID: 27186947]
[89]
Pereira Suarez AL, Lorenzetti MA, Gonzalez Lucano R, et al. Presence of human papilloma virus in a series of breast carcinoma from Argentina. PLoS One 2013; 8(4): e61613-3.
[http://dx.doi.org/10.1371/journal.pone.0061613] [PMID: 23637866]
[90]
Piana AF, Sotgiu G, Muroni MR, Cossu-Rocca P, Castiglia P, De Miglio MR. HPV infection and triple-negative breast cancers: An Italian case-control study. Virol J 2014; 11: 190-0.
[http://dx.doi.org/10.1186/s12985-014-0190-3] [PMID: 25413873]
[91]
Silva RG Jr, da Silva BB. No evidence for an association of human papillomavirus and breast carcinoma. Breast Cancer Res Treat 2011; 125(1): 261-4.
[http://dx.doi.org/10.1007/s10549-010-1129-z] [PMID: 20734131]
[92]
Wang YW, Zhang K, Zhao S, et al. HPV status and its correlation with BCL2, p21, p53, rb, and survivin expression in breast cancer in a Chinese population. BioMed Res Int 2017; 2017: 6315392.
[http://dx.doi.org/10.1155/2017/6315392] [PMID: 29423411]
[93]
Wang YX, Zhang ZY, Wang JQ, Qian XL, Cui J. HPV16 E7 increases COX-2 expression and promotes the proliferation of breast cancer. Oncol Lett 2018; 16(1): 317-25.
[http://dx.doi.org/10.3892/ol.2018.8624] [PMID: 29928417]
[94]
Widschwendter A, et al. Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol 2004; 31(4): 292-7.
[http://dx.doi.org/10.1016/j.jcv.2004.06.009]
[95]
Wrede D, Luqmani YA, Coombes RC, Vousden KH. Absence of HPV 16 and 18 DNA in breast cancer. Br J Cancer 1992; 65(6): 891-4.
[http://dx.doi.org/10.1038/bjc.1992.186] [PMID: 1319728]
[96]
Yan C, Teng ZP, Chen YX, Shen DH, Li JT, Zeng Y. Viral etiology relationship between human papillomavirus and human breast cancer and target of gene therapy. Biomed Environ Sci 2016; 29(5): 331-9.
[PMID: 27353707]
[97]
Yavuzer D, Salepci T, Karadayi N, Baloglu H, Kucukodaci Z. Human papillomavirus is not associated with breast carcinoma. Breast Cancer Res Treat 2010; 122(3): 899-900.
[http://dx.doi.org/10.1007/s10549-010-0963-3] [PMID: 20521097]
[98]
Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer 2000; 7(1): 33-6.
[http://dx.doi.org/10.1007/BF02967185] [PMID: 11029768]
[99]
Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins. Cancer Sci 2007; 98(10): 1505-11.
[http://dx.doi.org/10.1111/j.1349-7006.2007.00546.x] [PMID: 17645777]
[100]
Malik SS, Batool R, Masood N, Yasmin A. Risk factors for prostate cancer: A multifactorial case-control study. Curr Probl Cancer 2018; 42(3): 337-43.
[http://dx.doi.org/10.1016/j.currproblcancer.2018.01.014] [PMID: 29433825]
[101]
Whitaker NJ, Glenn WK, Sahrudin A, Orde MM, Delprado W, Lawson JS. Human papillomavirus and Epstein Barr virus in prostate cancer: Koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer. Prostate 2013; 73(3): 236-41.
[http://dx.doi.org/10.1002/pros.22562] [PMID: 22851253]
[102]
Anzivino E, Rodio DM, Mischitelli M, et al. High frequency of JCV DNA detection in prostate cancer tissues. Cancer Genomics Proteomics 2015; 12(4): 189-200.
[PMID: 26136219]
[103]
Zammarchi F, Pistello M, Piersigilli A, et al. MMTV‐like sequences in human breast cancer: A fluorescent PCR/laser microdissection approach. J Pathol 2006; 209(4): 436-44.
[104]
Al Dossary R, Alkharsah KR, Kussaibi H. Prevalence of Mouse Mammary Tumor Virus (MMTV)-like sequences in human breast cancer tissues and adjacent normal breast tissues in Saudi Arabia. BMC Cancer 2018; 18(1): 170.
[http://dx.doi.org/10.1186/s12885-018-4074-6] [PMID: 29426297]
[105]
zur Hausen H. Papillomaviruses in the causation of human cancers-A brief historical account. Virology 2009; 384(2): 260-5.
[http://dx.doi.org/10.1016/j.virol.2008.11.046] [PMID: 19135222]
[106]
Brady OJ, Osgood-Zimmerman A, Kassebaum NJ, et al. The association between Zika virus infection and microcephaly in Brazil 2015-2017: An observational analysis of over 4 million births. PLoS Med 2019; 16(3): e1002755.
[http://dx.doi.org/10.1371/journal.pmed.1002755] [PMID: 30835728]
[107]
Pasala S, Barr T, Messaoudi I. Impact of alcohol abuse on the adaptive immune system. Alcohol Res 2015; 37(2): 185-97.
[PMID: 26695744]

Rights & Permissions Print Cite
Article Metrics
17
1
© 2024 Bentham Science Publishers | Privacy Policy